Clinical Trial Update: Study of SHR-A2102 Combined Other Antitumor Drugs in Advanced Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating SHR-A2102 in combination with other antitumor drugs for advanced breast cancer. The study is currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• SHR-A2102

Snippet

Sponsor: Fudan University | Conditions: Advanced Breast Cancer | Phase 2 | Status: NOT_YET_RECRUITING